Skip to main content

Closed

WVE: Wave Life Sciences Ltd. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-4.4% / yr

Operating margin-333.4%

ROIC-43.8%

Financially safe

Stretched

Debt / equity0.10×

Interest coverage0.0×

Current ratio9.99×

Wave Life Sciences Ltd.

WVENASDAQ·USD·Closed

Wave Life Sciences Ltd.

WVENASDAQ·USD·Closed

$5.51

−4.34%

$5.51

−$0.25 (4.34%)

52W Range

3thpctl

Volume

0.86×avg

Mkt Cap

1.09BUSD

P/E

-5.1TTM

Div Yield

–ann

52W Range

3thpctl

Volume

0.86×avg

Market Cap

1.09BUSD

P/E Ratio

-5.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings